These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 26310825)

  • 1. Pharmacokinetics of Memantine after a Single and Multiple Dose of Oral and Patch Administration in Rats.
    Lee SH; Kim SH; Noh YH; Choi BM; Noh GJ; Park WD; Kim EJ; Cho IH; Bae CS
    Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):122-7. PubMed ID: 26310825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Depth Analysis of Pressure-Sensitive Adhesive Patch-Assisted Delivery of Memantine and Donepezil Using Physiologically Based Pharmacokinetic Modeling and in Vitro/in Vivo Correlations.
    Mittapelly N; Pandey G; Tulsankar SL; Arfi S; Bhatta RS; Mishra PR
    Mol Pharm; 2018 Jul; 15(7):2646-2655. PubMed ID: 29856631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative single-dose pharmacokinetics of rasagiline in minipigs after oral dosing or transdermal administration via a newly developed patch.
    Lin Y; Zou Y; Lin J; Zhang T; Deng J
    Xenobiotica; 2013 Aug; 43(8):705-10. PubMed ID: 23339547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled Iontophoretic Delivery
    Singhal M; Merino V; Rosini M; Cavalli A; Kalia YN
    Mol Pharm; 2019 Aug; 16(8):3460-3468. PubMed ID: 31241959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmaceutical answer to nonadherence: Once weekly oral memantine for Alzheimer's disease.
    Kanasty R; Low S; Bhise N; Yang J; Peeke E; Schwarz M; Wright J; Carter B; Moorthy S; Grant T; DeBenedictis B; Bishoff M; Simses C; Bellinger AM
    J Control Release; 2019 Jun; 303():34-41. PubMed ID: 30928488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study.
    Choi SH; Park KW; Na DL; Han HJ; Kim EJ; Shim YS; Lee JH;
    Curr Med Res Opin; 2011 Jul; 27(7):1375-83. PubMed ID: 21561398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPβCD-diclofenac (Dyloject) compared with other diclofenac formulations.
    Mermelstein F; Hamilton DA; Wright C; Lacouture PG; Ramaiya A; Carr DB
    Pharmacotherapy; 2013 Oct; 33(10):1012-21. PubMed ID: 23744759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of truncated area under the curves in the bioequivalence evaluation of long half-life drugs. Studies with donepezil and memantine.
    Erkent U; Koytchev R
    Arzneimittelforschung; 2008; 58(5):255-8. PubMed ID: 18589560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Pharmacokinetic Drug⁻Drug Interaction Between Harmine, a Cholinesterase Inhibitor, and Memantine, a Non-Competitive
    Zhang Y; Li S; Wang Y; Deng G; Cao N; Wu C; Ding W; Wang Y; Cheng X; Wang C
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30978991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous pharmacokinetics and bioavailability of memantine after subtenon, intravenous, and intravitreal administration in rabbits.
    Prieto E; Pérez S; Pablo LE; García MA; Bregante MA
    J Ocul Pharmacol Ther; 2014 Jun; 30(5):392-9. PubMed ID: 24597794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations.
    Göhler K; Brett M; Smit JW; Rengelshausen J; Terlinden R
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):338-48. PubMed ID: 23357834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.
    Lefèvre G; Sedek G; Jhee SS; Leibowitz MT; Huang HL; Enz A; Maton S; Ereshefsky L; Pommier F; Schmidli H; Appel-Dingemanse S
    Clin Pharmacol Ther; 2008 Jan; 83(1):106-14. PubMed ID: 17522596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.
    Monbaliu J; Verhaeghe T; Willems B; Bode W; Lavrijsen K; Meuldermans W
    Arzneimittelforschung; 2003; 53(7):486-95. PubMed ID: 12918214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects.
    Yao C; Raoufinia A; Gold M; Nye JS; Ramael S; Padmanabhan M; Walschap Y; Verhaeghe T; Zhao Q
    J Clin Pharmacol; 2005 May; 45(5):519-28. PubMed ID: 15831775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic Properties of Memantine after a Single Intraperitoneal Administration and Multiple Oral Doses in Euploid Mice and in the Ts65Dn Mouse Model of Down's Syndrome.
    Victorino DB; Bederman IR; Costa ACS
    Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):382-389. PubMed ID: 28557265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.